• Entity registrant name: KAMADA LTD (CIK: 0001567529)
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1567529/000117891318000767/0001178913-18-000767-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1567529/000117891318000767/kmda-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • XBRL Cloud Rendering (requires license): Click to open XBRL Cloud Component Rendering
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001567529
  • Open this page in separate window: Click

    • * * *

    Component: (Network and Table)
    Network
    00000005 - Statement - Consolidated Statements of Cash Flows
    (http://kamadaltd.com/role/StatementsOfCashFlows)
    Table (Implied)
    Slicers (applies to each fact value in each table cell)
    Reporting Entity [Axis] 0001567529 (http://www.sec.gov/CIK)
    Statement of cash flows [abstract] Period [Axis]
    2017-01-01 - 2017-12-31
    2016-01-01 - 2016-12-31
    2015-01-01 - 2015-12-31
    Statement of cash flows [abstract]
     
     
     
    Cash Flows from Operating Activities
     
     
     
    Net income (loss)
    6,901,000  
    (6,733,000) 
    (11,270,000) 
    Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
     
     
     
    Adjustments to the profit or loss items:
     
     
     
    Depreciation and impairment
    3,523,000  
    3,501,000  
    3,227,000  
    Financial expenses (income), net
    274,000  
    (470,000) 
    (154,000) 
    Cost of share-based payment
    483,000  
    1,071,000  
    1,907,000  
    Income tax expense
    269,000  
    1,722,000  
    xsi:nil  
    Gain from sale of property and equipment
    (52,000) 
    (18,000) 
    xsi:nil  
    Change in employee benefit liabilities, net
    166,000  
    (87,000) 
    87,000  
    Adjustments to the profit or loss items
    4,663,000  
     
    5,719,000  
     
    5,067,000  
     
    Changes in asset and liability items:
     
     
     
    Decrease (increase) in trade receivables, net
    (9,967,000) 
    3,489,000  
    (5,604,000) 
    Decrease in other accounts receivables
    328,000  
    211,000  
    118,000  
    Decrease (increase) in inventories
    4,524,000  
    742,000  
    (913,000) 
    Decrease (increase) in deferred expenses
    594,000  
    (433,000) 
    (565,000) 
    Increase (decrease) in trade payables
    (838,000) 
    (2,650,000) 
    887,000  
    Increase in other accounts payables
    71,000  
    1,520,000  
    94,000  
    Increase (decrease) in deferred revenues
    (2,930,000) 
    1,035,000  
    (2,405,000) 
    Changes in asset and liability items
    (8,218,000) 
     
    3,914,000  
     
    (8,388,000) 
     
    Cash received (paid) during the year for:
     
     
     
    Interest paid
    (21,000) 
    (60,000) 
    (484,000) 
    Interest received
    399,000  
    842,000  
    1,143,000  
    Taxes paid
    (116,000) 
    (1,785,000) 
    (47,000) 
    Cash received (paid) during the year
    262,000  
     
    (1,003,000) 
     
    612,000  
     
    Net cash provided by (used in) operating activities
    3,608,000  
     
    1,897,000  
     
    (13,979,000) 
     
    Cash Flows from Investing Activities
     
     
     
    Proceeds from sale of (investment in) short term investments, net
    (11,501,000) 
    4,236,000  
    13,971,000  
    Purchase of property and equipment and intangible assets
    (4,167,000) 
    (2,641,000) 
    (2,718,000) 
    Proceeds from sale of property and equipment
    60,000  
    42,000  
    xsi:nil  
    Net cash provided by (used in) investing activities
    (15,608,000) 
     
    1,637,000  
     
    11,253,000  
     
    Cash Flows from Financing Activities
     
     
     
    Proceeds from exercise of warrants and options
    3,000  
    xsi:nil 1
    1,254,000  
    Receipt of long-term loans
    279,000  
    1,701,000  
    197,000  
    Repayment of long-term loans
    (530,000) 
    (211,000) 
    (9,000) 
    Repayment of convertible debentures
    xsi:nil  
    xsi:nil  
    (7,797,000) 
    Proceeds from issuance of ordinary shares, net
    15,568,000  
    xsi:nil  
    xsi:nil  
    Net cash provided by (used in) financing activities
    15,320,000  
     
    1,490,000  
     
    (6,355,000) 
     
    Exchange differences on balances of cash and cash equivalent
    (607,000) 
    (103,000) 
    (418,000) 
    Increase (decrease) in cash and cash equivalents
    2,713,000  
     
    4,921,000  
     
    (9,499,000) 
     
    Cash and cash equivalents at the beginning of the year
    9,968,000  
    5,047,000  
    14,546,000  
    Cash and cash equivalents at the end of the year
    12,681,000  
     
    9,968,000  
     
    5,047,000  
     
    Significant non-cash transactions
     
     
     
    Purchase of property and equipment through capital lease
    282,000  
    132,000  
    xsi:nil  
    Purchase of property and equipment
    1,681,000  
    1,968,000  
    xsi:nil  
    Exercise of convertible debentures into shares
    		      
    1: Represent an amount of less than 1 thousands